New Zealand markets closed

Sartorius Stedim Biotech S.A. (SRTOY)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
18.400.00 (0.00%)
At close: 03:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.43B
Enterprise value 20.26B
Trailing P/E 47.32
Forward P/E 26.74
PEG ratio (5-yr expected) 1.06
Price/sales (ttm)5.28
Price/book (mrq)5.86
Enterprise value/revenue 6.80
Enterprise value/EBITDA 24.98

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-30.59%
S&P500 52-week change 324.96%
52-week high 331.80
52-week low 316.55
50-day moving average 321.46
200-day moving average 324.12

Share statistics

Avg vol (3-month) 33.78k
Avg vol (10-day) 3233
Shares outstanding 5972.91M
Implied shares outstanding 6975.75M
Float 829.29M
% held by insiders 10.00%
% held by institutions 10.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.07
Forward annual dividend yield 40.44%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 442.67%
Dividend date 318 Apr 2024
Ex-dividend date 402 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.38%
Operating margin (ttm)16.49%

Management effectiveness

Return on assets (ttm)3.92%
Return on equity (ttm)8.15%

Income statement

Revenue (ttm)2.72B
Revenue per share (ttm)2.91
Quarterly revenue growth (yoy)-8.20%
Gross profit (ttm)N/A
EBITDA 635.8M
Net income avi to common (ttm)254.7M
Diluted EPS (ttm)0.36
Quarterly earnings growth (yoy)-49.50%

Balance sheet

Total cash (mrq)695.1M
Total cash per share (mrq)7.19
Total debt (mrq)3.19B
Total debt/equity (mrq)82.46%
Current ratio (mrq)2.13
Book value per share (mrq)39.62

Cash flow statement

Operating cash flow (ttm)636.2M
Levered free cash flow (ttm)27.25M